PACS reported FY 2025 revenue of USD 5.29 billion (up 29.3%), net income of USD 191.5 million, adjusted EBITDA of USD 505.0 million and adjusted EBITDAR of USD 883.9 million. In Q4 2025, revenue was USD 1.36 billion (up 12.4%), net income was USD 59.8 million, adjusted EBITDA was USD 142.1 million and adjusted EBITDAR was USD 237.7 million. For FY 2026, PACS guided for revenue of USD 5.65 billion to USD 5.75 billion and adjusted EBITDA of USD 555 million to USD 575 million. The company said 207 facilities, or 73.4% of its skilled nursing portfolio, achieved a 4 or 5 star CMS Quality Measure Star rating, while mature facilities occupancy was 94.9% versus an industry average of 78.7%, and mature facilities skilled mix was 33.4%. PACS reported cash provided by operating activities of USD 404.2 million in FY 2025 and cash and cash equivalents of USD 197.0 million as of Dec. 31, 2025. During 2025, it added 8 operating facilities, and since the end of Q4 it added 3 facilities and divested one, bringing total operated facilities to 323 and properties wholly owned or owned through JV partnerships to 105 across 17 states.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PACS Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002001184-26-000002), on February 26, 2026, and is solely responsible for the information contained therein.
Comments